India Exchange Filings

IKS Health Q2 FY27 Investor Presentation

Inventurus Knowledge Solutions Ltd reports Q2 FY27 revenue of ₹15,925 mn, up 103.9% YoY

  • EBITDA margin was 27.7%, versus 33.0% in Q1 FY27 and 34.8% in Q2 FY26.
  • Profit attributable to IKS shareholders rose 20.4% YoY to ₹2,176 mn.
  • Q2 results included 82 days of TruBridge consolidation.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.